Brevan Howard Capital Management LP Bio Rad Laboratories, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 11,083 shares of BIO stock, worth $3.93 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,083
Previous 2,258
390.83%
Holding current value
$3.93 Million
Previous $616,000
501.95%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BIO
# of Institutions
453Shares Held
18.3MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$677 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$550 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$463 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$385 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$253 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.74B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...